Gamma Knife Market Anticipated to Reach USD 311.4 Million by 2033 - Persistence Market Research

Gamma Knife Market Overview

The global Gamma Knife market has witnessed steady growth in recent years, with a significant uptick in demand due to its non-invasive, precise, and effective treatment capabilities for various neurological disorders, particularly brain tumors. In 2022, the market revenue was valued at approximately USD 185.7 million, and it is projected to expand at a compound annual growth rate (CAGR) of 4.8%, reaching a market value of around USD 311.4 million by 2033. The increasing adoption of gamma knife radiosurgery (GKRS), particularly in regions with high healthcare spending, is one of the primary factors driving this growth. This procedure offers precise, non-invasive treatment options for patients suffering from brain metastases, vascular malformations, and other neurological conditions, contributing to its rapid acceptance in medical settings worldwide.

The leading segment within the Gamma Knife market is the head segment, which accounted for approximately 88.6% of the market share in 2022. This is due to the procedure's predominant use in treating brain-related conditions such as brain tumors, which are increasingly prevalent across various populations. Geographically, North America, particularly the United States, leads the market with a 40.8% share, largely driven by the increasing prevalence of brain cancers, rising disposable incomes, and the growing adoption of advanced non-invasive medical technologies. The U.S. healthcare system, known for its technological advancements and high healthcare expenditure, is likely to remain a dominant force in shaping the market's future trajectory.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/3742

Key Highlights from the Report

• The Gamma Knife market was valued at USD 185.7 million in 2022, with projections indicating a rise to USD 311.4 million by 2033.
• The global market is expected to grow at a CAGR of 4.8% during the forecast period from 2023 to 2033.
• Brain metastasis treatments contribute to around 69.2% of the overall market.
• Non-invasive gamma knife procedures are gaining popularity due to their faster recovery times and reduced side effects.
• The U.S. is the largest regional market, accounting for about 12.7% of the global market share.
• The head segment dominates the market, comprising around 88.6% of total sales in 2022.

Market Segmentation

Product Type & End-User Segmentation

The Gamma Knife market can be broadly segmented by product type, focusing on the various devices available in the market for stereotactic radiosurgery. The Leksell Gamma Knife, developed by Elekta, is one of the leading devices used in the treatment of brain tumors and other neurological conditions. Another segment is based on the end-users, which include hospitals, clinics, and specialized cancer centers that perform radiosurgery. Hospitals dominate the end-user segment, due to their advanced infrastructure, high patient volumes, and well-established expertise in handling complex surgeries.

The demand for these devices is also influenced by the increasing number of radiation therapy centers in both developed and emerging markets. The rising prevalence of neurological conditions, particularly in aging populations, is a key factor contributing to the growth of hospitals and specialized clinics as primary users of Gamma Knife equipment.

Disease Indication & Organ Treated

Another key aspect of market segmentation is based on disease indication and the specific organ being treated. Brain cancer, particularly brain metastases, holds the largest share of the Gamma Knife market, with a substantial portion of the market devoted to treating tumors in the head. Gamma Knife radiosurgery (GKRS) is especially effective in treating brain tumors and other disorders in the cranial area due to its precision in targeting abnormal tissue while minimizing damage to surrounding healthy tissue. Additionally, the increasing use of GKRS for vascular malformations and other neurological disorders such as epilepsy and Parkinson's disease further drives this segment's growth.

Regional Insights

North America

North America, and the U.S. in particular, is the leading region in the Gamma Knife market, accounting for approximately 40.8% of the global market share. This dominance is driven by high healthcare spending, the presence of advanced medical infrastructure, and the rising demand for non-invasive cancer treatments. Moreover, the growing prevalence of neurological disorders, including brain tumors, in the U.S. population, continues to fuel demand for more efficient and less invasive treatment options like Gamma Knife radiosurgery. The approval of various combination treatments that include immunotherapy and Gamma Knife is also contributing to the region's rapid market growth.

Europe

Germany and the U.K. are the primary contributors to the growth of the Gamma Knife market in Europe. The rising number of patients suffering from brain diseases, particularly Alzheimer's, combined with technological advancements in medical equipment, has propelled the market in this region. In Germany, for example, more than 1.5 million people are living with Alzheimer's, leading to a growing need for effective treatment options such as Gamma Knife radiosurgery. The region's robust healthcare infrastructure and government support for advanced medical technology also help boost demand for Gamma Knife procedures.

Market Drivers

The Gamma Knife market is primarily driven by the rising prevalence of neurological disorders and the increasing adoption of non-invasive treatment options. Brain cancer is one of the most prevalent types of cancer globally, with brain metastases being the most common type of cancer affecting the brain. As the global population ages, the incidence of neurological disorders such as Alzheimer's, Parkinson's disease, and epilepsy is also on the rise, leading to a growing demand for Gamma Knife procedures. Non-invasive treatments, which offer faster recovery times and fewer side effects compared to traditional surgery, are becoming increasingly popular among patients, further driving the market's growth.

Market Restraints

One of the primary challenges faced by the Gamma Knife market is the high cost of Gamma Knife machines and treatments. Gamma Knife radiosurgery is significantly more expensive compared to other forms of radiation therapy, which limits its accessibility in emerging economies. The initial cost of a Gamma Knife system can range from USD 7 million to USD 10 million, which includes the purchase price, installation, and maintenance. Moreover, the need for cobalt-60 radiation sources that must be replaced periodically adds to the operational cost. These high costs, combined with low awareness about the treatment in some regions, present significant barriers to market growth, particularly in lower-income countries.

Market Opportunities

The growing demand for non-invasive cancer treatment solutions presents a significant opportunity for the Gamma Knife market. As awareness about the benefits of Gamma Knife radiosurgery continues to spread, the market is expected to grow rapidly in emerging economies where healthcare infrastructure is improving. Additionally, advancements in combination therapies, such as the use of immunotherapy in conjunction with Gamma Knife treatment, offer exciting opportunities for market expansion. Companies investing in research and development to enhance the precision and affordability of Gamma Knife systems will likely lead the market into a new phase of growth.

Reasons to Buy the Report

✔ Comprehensive analysis of the Gamma Knife market, including forecasts and growth drivers.
✔ Detailed segmentation by product type, disease indication, and geographical regions.
✔ Insights into the latest technological advancements in Gamma Knife systems.
✔ Identification of key players and competitive landscape in the market.
✔ Strategic recommendations for businesses looking to enter or expand in the Gamma Knife market.

Company Insights

Key players in the Gamma Knife market include:

• Elekta AB
• Varian Medical Systems
• Huiheng Medical, Inc.
• MASEP Medical Science Technology Development (Shenzhen) Co., Ltd.
• Akesis Inc.
• Cyber Medical Corporation Limited
• Masep Infini Global, Inc.
• Nordion, Inc.
• Hokai
• ET Medical Group
• American Shared Hospital Services

Recent Developments

1. Elekta launched Elekta Esprit in May 2022, which offers clinicians faster, automated treatment planning, improving patient outcomes.

2. Elekta also introduced Icon in May 2022, featuring frameless, mask-based radiosurgery, enhancing treatment efficiency and precision in neurological care.

This report provides detailed insights and actionable data for businesses and healthcare providers looking to understand the dynamics of the Gamma Knife market and make informed strategic decisions.

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

This release was published on openPR.